Chronic Malignancies Working Party (CMWP)
Lymphoma Working Party (LWP)
Study type:
Study number:
2013-N-02
Type of treatment:
Diseases:
Chronic Lymphocytic Leukaemia (CLL)
Non-Hodgkin’s Lymphoma (NHL)
Short title:
BCRi survey
Primary objective:
OBJECTIVE: To assess safety and efficacy of HSCT after previous exposure to BCRi/BCL2a
Key inclusion criteria:
First allogeneic HSCT, diagnosis of MCL, CLL, FL, WM or DLBCL, age over 18 years at transplant, allografted 2013-March 2015, donor SIB or well or partially matched unrelated, any conditioning regimen, documented pre-transplant exposure to BCRi/BCL2a
Country:
Principal investigator:
Peter Dreger, Johannes Schetelig
EBMT Study coordinator:
Hervé Finel